Lanxess is targeting EBITDA pre exceptionals of approximately € 1.4 billion in 2015. The specialty chemicals company plans to achieve its mid-term earnings target through a dual-track growth strategy of organic and external growth (c.f. article on the left). CHEManager Europe asked CEO Dr. Axel C. Heitmann about the key elements of the company's strategy.
CHEManager: Dr. Heitmann, the global economic recovery only set in a year ago but you are already setting an ambitious growth target for the future. What makes you so confident?
Dr. Heitmann: Lanxess has transformed itself over the last six years into a financially solid company with a strong platform for growth. By the end of this year, we will have increased EBITDA pre exceptionals by roughly 80 percent since 2004, even in spite of the global economic crisis. This clearly underlines our successful track record to deliver sustainable growth. So it is only consistent that we are now targeting another 80 percent increase in earnings....